Treatment of opioid-induced constipation with oral naloxone: a pilot study.
about
Mu-opioid antagonists for opioid-induced bowel dysfunctionChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsAlvimopanOpioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategiesStrong opioids for cancer painRandomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.Recent advances in the use of opioids for cancer painManagement of opioid-induced gastrointestinal effects in patients receiving palliative care.Pharmacotherapy of addictions.Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.Anticipating and treating opioid-associated adverse effects.Opioids, dopamine, stress, and the addictions.Assessing and managing opiate-induced constipation in adults with cancer.Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in miceEfficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate responseMethylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.Effects of methylnaltrexone on guinea pig gastrointestinal motility.Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileusEffectiveness of two opioid antagonists in treating opioid-induced constipation.Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.Naloxone treatment for irritable bowel syndrome--a randomized controlled trial with an oral formulation.Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial.Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases.Slowing of intestinal transit by fat depends on naloxone-blockable efferent, opioid pathway.Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.Effect of an enteric-release formulation of naloxone on intestinal transit in volunteers taking codeine.A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.Prolonged-release naloxone can cause systemic opioid withdrawal.Enteral administration of naloxone for treatment of opioid-associated intragastric feeding intolerance.Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study.Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.Opioid-induced constipation.Effect of acupuncture on post-hemorrhoidectomy pain: a randomized controlled trial
P2860
Q24243268-80CD97BA-D7BE-4C4E-AC1A-31ABB8DB80B9Q28079705-61563928-880D-46C2-9A16-0046CD2C6E08Q28249359-FF97D77F-971E-4FA6-907B-E6AD1CE5E481Q28294194-77F14982-945A-480C-BA05-AA9E535B51CAQ28353103-DBDCB498-B4F4-4169-9419-41761A4FB3D0Q33462549-301A8F4C-E665-4610-87D5-AC8379DDCF69Q33520508-FF2ECF01-630A-4708-A677-BB971FA5D3F8Q33643136-5C1B0703-A5BE-49A8-96BE-E5CF27901F36Q34418203-E23811E7-B119-46BD-8811-12292B40E95DQ34523889-F989711F-0EC7-4610-AD22-122FB9F72A17Q34810395-82F6F092-F50B-4DFA-9FAC-256AA76C5705Q35028902-032F85DE-0BAF-482C-8C9A-4456615052D5Q35194392-C02D9E60-9605-4D00-9DEC-303D47A19FAEQ35454821-59C52787-5A0A-4B31-AF48-1F39C1698D99Q35778556-650096FA-5B90-4CC7-9919-178CB15EEA96Q36178704-237ED98E-BFE4-4CB3-9456-A1C80031DF16Q36223541-03F89F9A-5728-4872-B7FD-9C0CDD8FDC59Q36458384-67F325CB-3642-4007-BAFC-D706CEEDC437Q36480105-D8F6D531-83B6-472C-8012-CC4A425603EAQ36823204-7CB19EF1-1DD4-4A1C-BF47-66BBDC61C002Q36854395-09CD9471-088F-44B1-B4C2-9AC57CF37252Q37077184-F634AF5B-A265-48E6-9D1C-572A3FFBA099Q37601903-3275F830-2751-45FB-8945-A6C1416FE94FQ37686927-B2E07DB6-68C9-44B7-8BEE-5D2E405D9D72Q39229690-524669C8-BC03-46BE-B2BB-55DE331C0E72Q39403721-81C9200F-7D65-45F1-9F51-339E4C20B540Q39450187-298A3F70-D2DF-41E6-B48E-3974874A8E4AQ41247930-4480C0A6-7ADE-4D42-9489-5CD51D03A153Q41742160-FC0E5D01-14CC-491B-8931-F3DE463D8ACBQ43266400-DCE942EC-DD56-4011-AC1B-2624690CCC85Q43591803-7A7037C2-E707-43D6-8AA4-56E0E65B6F09Q44339976-AAFBD4EE-855C-4151-9083-3A249F6B3A6BQ44342855-702F0C24-38FD-4446-9C2B-F1A5FA530F28Q44343515-B0AF3BBE-4D76-4E32-BC9B-CE196F7AE0BCQ44344708-FAA80C98-865E-4825-B499-42BB4BE2A23AQ45219303-2A44E3E8-C3F4-4301-A311-69D249D5BE6FQ46353403-7B5F0115-C143-4BBC-94FE-67303E727D9AQ48443031-548A6527-BC5C-4A39-B82A-ADF2EEB109C2Q54262333-169F5B0C-6337-4856-BE31-880D7B3BE789Q58799239-32EE9E0C-0FBB-4F56-8156-CBB120A099CE
P2860
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@en
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@nl
type
label
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@en
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@nl
prefLabel
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@en
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@nl
P2093
P356
P1476
Treatment of opioid-induced constipation with oral naloxone: a pilot study.
@en
P2093
Culpepper-Morgan JA
Inturrisi CE
Portenoy RK
P356
10.1038/CLPT.1992.106
P407
P577
1992-07-01T00:00:00Z